Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Zaharie (Bucharest, Romania), V. Cosei (Bucure?ti, Romania), A. Croitoru (Bucure?ti, Romania), L. Davidescu (Oradea, Romania), J. Chorostowska-Wynimko (Warsaw, Poland), R. Ulmeanu (Bucure?ti, Romania). Diagnosing alpha-1 antitrypsin deficiency in Romania - first 1000 cases tested. 1130

Member's Comments

No comment yet.

Related content which might interest you: Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Alpha 1 - antitrypsin deficiency: diagnosis and treatment Source: Virtual Congress 2021 – Alpha 1 - antitrypsin deficiency: diagnosis and treatment Year: 2021 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Alpha-1 antitrypsin deficiency and lung cancer: Description of a cohort of patients in northwestern Spain Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 The undiagnosed disease burden associated with alpha-1 antitrypsin deficiency genotypes Source: Eur Respir J, 56 (6) 2001441; 10.1183/13993003.01441-2020 Year: 2020 Trends in diagnosis and clinical presentation of alpha-1 antitrypsin deficiency within an Irish population Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Late Breaking Abstract - Genetic diagnosis of alpha-1 antitrypsin deficiency using saliva samples Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 The national alpha-1 antitrypsin deficiency registry in Poland Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 Alpha-1 antitrypsin deficiency – a potentially fatal disease Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Rare alpha-1 antitrypsin mutations in the Irish population Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases Year: 2011 The Irish national alpha-1 antitrypsin deficiency targeted detection programme Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Alpha-1 antitrypsin deficiency severity and the risk of COVID-19 Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Estimates of the prevalence of alpha-1 antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe Source: Eur Respir J 2005; 26: Suppl. 49, 219s Year: 2005 Anxiety in a population tested for alpha-1 antitrypsin deficiency. Source: International Congress 2019 – Genes and environment Year: 2019 Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in! Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020